enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors [Yahoo! Finance]
Nkarta, Inc. (NKTX)
Company Research
Source: Yahoo! Finance
company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), today announced the election of Paul Hastings and Wouter Joustra as new members of its Board of Directors at the Company's 2024 annual meeting of shareholders. Shareholders also reelected incumbent director Lota Zoth. Each will serve a three-year term expiring at the 2027 annual meeting of shareholders. enGene's Board is now comprised of seven members including Richard Glickman (Chairman), Gerald Brunk, Jasper Bos, and Jason Hanson. "We are pleased to welcome Paul and Wouter to our Board of Directors. Their breadth of biopharma industry experience across research, corporate management and finance equips them well to serve as Board members of enGene, particularly as we look to the potential expansion of our pipeline across additional urological indications and move towards our planned BLA filing for EG-70 in the first quarter of 2026," said Jason Hanson, C
Show less
Read more
Impact Snapshot
Event Time:
NKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NKTX alerts
High impacting Nkarta, Inc. news events
Weekly update
A roundup of the hottest topics
NKTX
News
- Nkarta to Participate in Upcoming Investor ConferenceGlobeNewswire
- Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at HC Wainwright from $23.00 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Why Nkarta Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
- Nkarta, Inc. (NASDAQ: NKTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $13.00 price target on the stock.MarketBeat
- Nkarta, Inc. (NASDAQ: NKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $16.00 price target on the stock.MarketBeat
NKTX
Earnings
- 8/13/24 - Beat
NKTX
Sec Filings
- 8/23/24 - Form 4
- 8/16/24 - Form 8-K/A
- 8/13/24 - Form 10-Q
- NKTX's page on the SEC website